🇺🇸 FDA
Patent

US 10702541

Stimulation of an immune response by enantiomers of cationic lipids

granted A61KA61K31/685A61P

Quick answer

US patent 10702541 (Stimulation of an immune response by enantiomers of cationic lipids) held by PDS Biotechnology Corporation expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PDS Biotechnology Corporation
Grant date
Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/685, A61P, A61P31/00, A61P31/12